Trial Profile
Phase I clinical trial of vinorelbine (Navelbine) and trastuzumab (Herceptin) in patients with carcinoma of the breast or non-small cell lung cancer and HER-2/NEU overexpression
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary) ; Trastuzumab
- Indications Advanced breast cancer; Non-small cell lung cancer
- Focus Adverse reactions
- 09 Sep 2005 New trial record.